Yokukansan promotes hippocampal neurogenesis associated with the suppression of activated microglia in Gunn rat

Journal of Neuroinflammation

Volumn 10, Issue , 2013, Pages

  Furuya, Motohide ^a   Miyaoka, Tsuyoshi ^a   Tsumori, Toshiko ^a,b   Liaury, Kristian ^a   Hashioka, Sadayuki ^a   Wake, Rei ^a   Tsuchie, Keiko ^a   Fukushima, Michiyo ^a   Ezoe, Satoko ^a,c   Horiguchi, Jun ^a  

^a SHIMANE UNIVERSITY FACULTY OF MEDICINE   (Japan)

^b PREFECTURAL UNIVERSITY OF HIROSHIMA   (Japan)

^c SHIMANE UNIVERSITY   (Japan)

Author keywords

Anti inflammatory action; Cognitive function; Microglia; Neurogenesis; Schizophrenia (231 350); Unconjugated bilirubin; Yokukansan

Indexed keywords

KAMPO; UNCLASSIFIED DRUG; YOKUKANSAN;

ANGELICA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATRACTYLODES; ATRACTYLODES LANCEA; BUPLEURUM; CELL ACTIVATION; CNIDIUM; CONTROLLED STUDY; DENTATE GYRUS; DRUG EFFICACY; GLYCYRRHIZA; GUNN RAT; HIPPOCAMPUS; INHIBITION KINETICS; MALE; MICROGLIA; NERVE CELL DIFFERENTIATION; NONHUMAN; PORIA; RAT; SCHIZOPHRENIA; SPATIAL MEMORY; UNCARIA; WORKING MEMORY;

ANIMALS; DISEASE MODELS, ANIMAL; DRUGS, CHINESE HERBAL; FLUORESCENT ANTIBODY TECHNIQUE; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MALE; MICROGLIA; MICROSCOPY, CONFOCAL; NEUROGENESIS; RATS; RATS, GUNN; RATS, WISTAR; SCHIZOPHRENIA;

EID: 84889046296     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-10-145     Document Type: Article

References (58)

1. Van Os J, Kapur S. Schizophrenia. Lancet 2009, 374:635-645. 10.1016/S0140-6736(09)60995-8, 19700006.
2. DeCarolis NA, Eisch AJ. Hippocampal neurogenesis as a target for the treatment of mental illness: a critical evaluation. Neuropharmacology 2010, 58:884-893. 10.1016/j.neuropharm.2009.12.013, 2839019, 20060007.
3. Toulopoulou T, Grech A, Morris RG, Schulze K, McDonald C, Chapple B, Rabe-Hesketh S, Murray RM. The relationship between volumetric brain changes and cognitive function: a family study on schizophrenia. Biol Psychiatry 2004, 56:447-453. 10.1016/j.biopsych.2004.06.026, 15364043.
4. Kohman RA, Rhodes JS. Neurogenesis, inflammation and behavior. Brain Behav Immun 2013, 27(1):22-32.
5. Doorduin J, De Vries EF, Willemsen AT, De Groot JC, Dierckx RA, Klein HC. Neuroinflammation in schizophrenia-related psychosis: a PET study. J Nucl Med 2009, 50:1801-1807. 10.2967/jnumed.109.066647, 19837763.
6. Sommer IE, De Witte L, Begemann M, Kahn RS. Nonsteroidal anti-inflammatory drugs in schizophrenia: ready for practice or a good start? A meta-analysis. J Clin Psychiatry 2012, 73:414-419. 10.4088/JCP.10r06823, 22225599.
7. Miyaoka T, Seno H, Itoga M, Iijima M, Inagaki T, Horiguchi J. Schizophrenia-associated idiopathic unconjugated hyperbilirubinemia (Gilbert's syndrome). J Clin Psychiatry 2000, 61:868-871. 10.4088/JCP.v61n1110, 11105741.
8. Radhakrishnan R, Kanigere M, Menon J, Calvin S, Janish A, Srinivasan K. Association between unconjugated bilirubin and schizophrenia. Psychiatry Res 2011, 189:480-482. 10.1016/j.psychres.2011.03.003, 21470692.
9. Gordo AC, Falcao AS, Fernandes A, Brito MA, Silva RF, Brites D. Unconjugated bilirubin activates and damages microglia. J Neurosci Res 2006, 84:194-201. 10.1002/jnr.20857, 16612833.
10. Hayashida M, Miyaoka T, Tsuchie K, Yasuda H, Wake R, Nishida A, Inagaki T, Toga T, Nagami H, Oda T, Horiguchi J. Hyperbilirubinemia-related behavioral and neuropathological changes in rats: a possible schizophrenia animal model. Prog Neuropsychopharmacol Biol Psychiatry 2009, 33:581-588. 10.1016/j.pnpbp.2009.02.013, 19249333.
11. Liaury K, Miyaoka T, Tsumori T, Furuya M, Wake R, Ieda M, Tsuchie K, Taki M, Ishihara K, Tanra AJ, Horiguchi J. Morphological features of microglial cells in the hippocampal dentate gyrus of Gunn rat: a possible schizophrenia animal model. J Neuroinflammation 2012, 9:56. 10.1186/1742-2094-9-56, 3334707, 22424389.
12. Tsuchie K, Miyaoka T, Furuya M, Liaury K, Ieda M, Wake R, Horiguchi J, Takechi M. The effects of antipsychotics on behavioral abnormalities of the Gunn rat (unconjugated hyperbilirubinemia rat), a rat model of schizophrenia. Asian J Psychiatr 2013, 6:119-123. 10.1016/j.ajp.2012.09.007, 23466107.
13. Miyaoka T, Furuya M, Yasuda H, Hayashida M, Nishida A, Inagaki T, Horiguchi J. Yi-gan san as adjunctive therapy for treatment-resistant schizophrenia: an open-label study. Clin Neuropharmacol 2009, 32:6-9. 10.1097/WNF.0b013e31817e08c3, 19471183.
14. Nishi A, Yamaguchi T, Sekiguchi K, Imamura S, Tabuchi M, Kanno H, Nakai Y, Hashimoto K, Ikarashi Y, Kase Y. Geissoschizine methyl ether, an alkaloid in Uncaria hook, is a potent serotonin (1) A receptor agonist and candidate for amelioration of aggressiveness and sociality by yokukansan. Neuroscience 2012, 207:124-136.
15. Ikarashi Y, Iizuka S, Imamura S, Yamaguchi T, Sekiguchi K, Kanno H, Kawakami Z, Yuzurihara M, Kase Y, Takeda S. Effects of yokukansan, a traditional Japanese medicine, on memory disturbance and behavioral and psychological symptoms of dementia in thiamine-deficient rats. Biol Pharm Bull 2009, 32:1701-1709. 10.1248/bpb.32.1701, 19801831.
16. Kawakami Z, Kanno H, Ueki T, Terawaki K, Tabuchi M, Ikarashi Y, Kase Y. Neuroprotective effects of yokukansan, a traditional Japanese medicine, on glutamate-mediated excitotoxicity in cultured cells. Neuroscience 2009, 159:1397-1407. 10.1016/j.neuroscience.2009.02.004, 19409210.
17. Hiratsuka T, Matsuzaki S, Miyata S, Kinoshita M, Kakehi K, Nishida S, Katayama T, Tohyama M. Yokukansan inhibits neuronal death during ER stress by regulating the unfolded protein response. PLoS One 2010, 5:e13280. 10.1371/journal.pone.0013280, 2953506, 20967273.
18. Iwasaki K, Satoh-Nakagawa T, Maruyama M, Monma Y, Nemoto M, Tomita N, Tanji H, Fujiwara H, Seki T, Fujii M, Arai H, Sasaki H. A randomized, observer-blind, controlled trial of the traditional Chinese medicine Yi-Gan San for improvement of behavioral and psychological symptoms and activities of daily living in dementia patients. J Clin Psychiatry 2005, 66:248-252. 10.4088/JCP.v66n0214, 15705012.
19. Miyaoka T, Furuya M, Yasuda H, Hayashia M, Inagaki T, Horiguchi J. Yi-gan san for the treatment of borderline personality disorder: an open-label study. Prog Neuropsychopharmacol Biol Psychiatry 2008, 32:150-154. 10.1016/j.pnpbp.2007.07.026, 17765378.
20. Tanaka Y, Mizoguchi K. Influence of aging on chondroitin sulfate proteoglycan expression and neural stem/progenitor cells in rat brain and improving effects of a herbal medicine, yokukansan. Neuroscience 2009, 164:1224-1234. 10.1016/j.neuroscience.2009.08.060, 19729050.
21. Gold JM. Cognitive deficits as treatment targets in schizophrenia. Schizophr Res 2004, 72:21-28. 10.1016/j.schres.2004.09.008, 15531404.
22. Barrantes-Vidal N, Aguilera M, Campanera S, Fatjo-Vilas M, Guitar M, Miret S, Valero S, Fañanás L. Working memory in siblings of schizophrenia patients. Schizophr Res 2007, 95:70-75. 10.1016/j.schres.2007.06.020, 17628433.
23. Murai T, Okuda S, Tanaka T, Ohta H. Characteristics of object location memory in mice: Behavioral and pharmacological studies. Physiol Behav 2007, 90:116-124. 10.1016/j.physbeh.2006.09.013, 17049363.
24. Makinodan M, Yamauchi T, Tatsumi K, Okuda H, Noriyama Y, Sadamatsu M, Kishimoto T, Wanaka A. Yi-Gan San restores behavioral alterations and a decrease of brain glutathione level in a mouse model of schizophrenia. J Brain Dis 2009, 1:1-6. 3676319, 23818802.
25. Fujiwara H, Takayama S, Iwasaki K, Tabuchi M, Yamaguchi T, Sekiguchi K, Ikarashi Y, Kudo Y, Kase Y, Arai H, Yaegashi N. Yokukansan, a traditional Japanese medicine, ameliorates memory disturbance and abnormal social interaction with anti-aggregation effect of cerebral amyloid β proteins in amyloid precursor protein transgenic mice. Neurosci 2011, 180:305-313.
26. Shinno H, Inami Y, Inagagi T, Nagamura Y, Horiguchi J. Effect of Yi-Gan San on psychiatric symptoms and sleep structure at patients with behavioral and psychological symptoms of dementia. Prog Neuropsychopharmacol Biol Psychiatry 2008, 32:881-885. 10.1016/j.pnpbp.2007.12.027, 18243460.
27. Imamura S, Tabuchi M, Kushida H, Nishi A, Kanno H, Yamaguchi T, Sekiguchi K, Ikarashi Y, Kase Y. The blood-brain barrier permeability of geissoschizine methyl ether in uncaria hook, a galenical constituent of the traditional Japanese medicine yokukansan. Cell Mol Neurobiol 2011, 31:787-793. 10.1007/s10571-011-9676-3, 21442303.
28. Tabuchi M, Imamura S, Kawakami Z, Ikarashi Y, Kase Y. The blood-brain barrier permeability of 18β-glycyrrhetinic acid, a major metabolite of glycyrrhizin in glycyrrhiza root, a constitutent of the traditional Japanese Medicine yokukansan. Cell Mol Neurobiol 2012, 32:1139-1146. 10.1007/s10571-012-9839-x, 22488528.
29. Kushida H, Fukutake M, Tabuchi M, Katsuhara T, Nishimura H, Ikarashi Y, Kanitani M, Kase Y. Simultaneous quantitative analyses of indole and oxindole alkaloids of Uncaria Hook in rat plasma and brain after oral administration of the traditional Japanese medicine yokukansan using high-performance liquid chromatography with tandem mass spectrometry. Biomed Chromatogr 2013, 27(12):1647-1656.
30. Imai Y, Ibata I, Ito D, Ohsawa K, Kohsaka S. A novel gene iba1 in the major histocompatibility complex class III region encoding an EF hand protein expressed in a monocytic lineage. Biochem Biophys Res Commun 1996, 224:855-862. 10.1006/bbrc.1996.1112, 8713135.
31. Sierra A, Encinas JM, Deudero JJ, Chancey JH, Enikolopov G, Overstreet-Wadiche LS, Tsirka SE, Maletic-Savatic M. Microglia shape adult hippocampal neurogenesis through apoptosis-coupled phagocytosis. Cell Stem Cell 2010, 7:483-495. 10.1016/j.stem.2010.08.014, 20887954.
32. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates 2007, London: Academic Press, 6.
33. Ge S, Yang CH, Hsu KS, Ming GL, Song H. A critical period for enhanced synaptic plasticity in newly generated neurons of the adult brain. Neuron 2007, 54:559-566. 10.1016/j.neuron.2007.05.002, 2040308, 17521569.
34. Winters BD, Bussey TJ. Transient inactivation of perirhinal cortex disrupts encoding, retrieval, and consolidation of object recognition memory. J Neurosci 2005, 25:52-61. 10.1523/JNEUROSCI.3827-04.2005, 15634766.
35. Bussey TJ, Duck J, Muir JL, Aggleton JP. Distinct patterns of behavioural impairments resulting from fornix transection or neurotoxic lesions of the perirhinal and postrhinal cortices in the rat. Behav Brain Res 2000, 111:187-202. 10.1016/S0166-4328(00)00155-8, 10840144.
36. Lee I, Hunsaker MR, Kesner RP. The role of hippocampal subregions in detecting spatial novelty. Behav Neurosci 2005, 119:145-153.
37. Or TC, Yang CL, Law AH, Li JC, Lau AS. Isolation and identification of anti-inflammatory constituents from Ligusticum chuanxiong and their underlying mechanisms of action on microglia. Neuropharmacology 2011, 60:823-831. 10.1016/j.neuropharm.2010.12.002, 21146552.
38. Kim YW, Zhao RJ, Park SJ, Lee JR, Cho IJ, Yang CH, Kim SG, Kim SC. Anti-inflammatory effects of liquiritigenin as a consequence of the inhibition of NF-kappaB-dependent iNOS and proinflammatory cytokines production. Br J Pharmacol 2008, 154:165-173. 10.1038/bjp.2008.79, 2438972, 18332856.
39. Yuan D, Ma B, Yang JY, Xie YY, Wang L, Zhang LJ, Kano Y, Wu CF. Anti-inflammatory effects of rhynchophylline and isorhynchophylline in mouse N9 microglial cells and the molecular mechanism. Int Immunopharmacol 2009, 9:1549-1554. 10.1016/j.intimp.2009.09.010, 19781666.
40. Lu CN, Yuan ZG, Zhang XL, Yan R, Zhao YQ, Liao M, Chen JX. Saikosaponin a and its epimer saikosaponin d exhibit anti-inflammatory activity by suppressing activation of NF-kappaB signaling pathway. Int Immunopharmacol 2012, 14:121-126. 10.1016/j.intimp.2012.06.010, 22728095.
41. Khaksa G, Zolfaghari ME, Dehpour AR, Samadian T. Anti-inflammatory and anti-nociceptive activity of disodium glycyrrhetinic acid hemiphthalate. Planta Med 1996, 62:326-328. 10.1055/s-2006-957894, 8792664.
42. Seo MJ, Kim SJ, Kang TH, Rim HK, Jeong HJ, Um JY, Hong SH, Kim HM. The regulatory mechanism of beta-eudesmol is through the suppression of caspase-1 activation in mast cell-mediated inflammatory response. Immunopharmacol Immunotoxicol 2011, 33:178-185. 10.3109/08923973.2010.491082, 20604677.
43. Cheng CY, Ho TY, Lee EJ, Su SY, Tang NY, Hsieh CL. Ferulic acid reduces cerebral infarct through its antioxidative and anti-inflammatory effects following transient focal cerebral ischemia in rats. Am J Chin Med 2008, 36:1105-1119. 10.1142/S0192415X08006570, 19051339.
44. Nukaya H, Yamashiro H, Fukazawa H, Ishida H, Tsuji K. Isolation of inhibitors of TPA-induced mouse ear edema from Hoelen. Poria cocos. Chem Pharm Bull (Tokyo) 1996, 44:847-849. 10.1248/cpb.44.847, 8681415.
45. Song Y, Qu R, Zhu S, Zhang R, Ma S. Rhynchophylline attenuates LPS-induced pro-inflammatory responses through down-regulation of MAPK/NF-kappaB signaling pathways in primary microglia. Phytother Res 2012, 26:1528-1533.
46. Ladeby R, Wirenfeldt M, Garcia-Overejo D, Fenger C, Dissing Olsen L, Dalmau I, Finsen B. Microglial cell population dynamics in the injured adult central nervous system. Brain Res Rev 2005, 48:196-206. 10.1016/j.brainresrev.2004.12.009, 15850658.
47. Hailer NP, Grampp A, Nitsch R. Proliferation of microglia and astrocytes in the dentate gyrus following entohirnal cortex lesion: a quantitative bromodeoxyuridine-labelling study. Eur J Neurosci 1999, 11:3359-3364. 10.1046/j.1460-9568.1999.00808.x, 10510203.
48. Kohman RA, Bhattacharya TK, Kilby C, Bucko P, Rhodes J. Effect of minocycline on spatial learning, hippocampal neurogenesis and microglia in aged and adult mice. Behv Brain Res 2013, 242:17-24.
49. Dean OM, Data-Franco J, Giorlando F, Berk M. Minocycline: therapeutic potential in psychiatry. CNS Drugs 2012, 26:391-401. 10.2165/11632000-000000000-00000, 22486246.
50. Solomon SD, McMurray JJ, Pfeffer MA, Wittes J, Fowler R, Finn P, Anderson WF, Zauber A, Hawk E, Bertagnolli M. Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention. N Engl J Med 2005, 352:1071-1080. 10.1056/NEJMoa050405, 15713944.
51. Derry S, Loke YK. Risk of gastrointestinal haemorrhage with long term use of aspirin: meta-analysis. BMJ 2000, 321:1183-1187. 10.1136/bmj.321.7270.1183, 27521, 11073508.
52. Vilacoba E, Almuzara M, Gulone L, Traglia GM, Figueroa SA, Sly G, Fernandez A, Centron D, Ramirez MS. Emergence and spread of plasmid-borne tet (B)::ISCR2 in minocycline-resistant acinetobacter baumannii isolates. Antimicrob Agents Chemother 2013, 57:651-654. 10.1128/AAC.01751-12, 3535920, 23147737.
53. Monje ML, Toda H, Palmer TD. Inflammatory blockade restores adult hippocampal neurogenesis. Science 2003, 302:1760-1765. 10.1126/science.1088417, 14615545.
54. Jakubs K, Bonde S, Iosif RE, Ekdahl CT, Kokaia Z, Kokaia M, Lindvall O. Inflammation regulates functional integration of neurons born in adult brain. J Neurosci 2008, 28:12477-12488. 10.1523/JNEUROSCI.3240-08.2008, 19020040.
55. Reif A, Fritzen S, Finger M, Strobel A, Lauer M, Schmitt A, Lesch KP. Neural stem cell proliferation is decreased in schizophrenia, but not in depression. Mol Psychiatry 2006, 11:514-522. 10.1038/sj.mp.4001791, 16415915.
56. Vita A, De Peri L, Silenzi C, Dieci M. Brain morphology in first-episode schizophrenia: a meta-analysis of quantitative magnetic resonance imaging studies. Schizophr Res 2006, 82:75-88. 10.1016/j.schres.2005.11.004, 16377156.
57. Duan X, Chang JH, Ge S, Faulkner RL, Kim JY, Kitabatake Y, Liu XB, Yang CH, Jordan JD, Ma DK, Liu CY, Ganesan S, Cheng HJ, Ming GL, Lu B, Song H. Disrupted-In-Schizophrenia 1 regulates integration of newly generated neurons in the adult brain. Cell 2007, 130:1146-1158. 10.1016/j.cell.2007.07.010, 2002573, 17825401.
58. Gazzin S, Berengeno AL, Strazielle N, Fazzari F, Raseni A, Ostrow JD, Wennberg R, Ghersi-Egea JF, Tiribelli C. Modulation of Mrp1 (ABCc1) and Pgp (ABCb1) by bilirubin at the blood-CSF and blood-brain barriers in the Gunn rat. PLoS One 2011, 6:e16165. 10.1371/journal.pone.0016165, 3031532, 21297965.